Biochemical Modulation: Its Pharmacological Basis and Clinical Applications: Symposium, Singapore, October 1995. Supplement Issue: Oncology 1997, Vol. 54, Suppl. 1 (Paperback)L.W. Hock (editor)
Paperback 40 Pages / Published: 26/11/1996
- Not available
Over the last decade the development of new cytotoxic agents, along with their effective integration into combination chemotherapy, has improved survival for many cancer patients. However, survival rates for patients with advanced disease have not been improved, and new therapeutic approaches are being investigated. One of these is the use of biochemical modulation, a strategy employing drugs that favorably alter the interaction of conventional chemotherapeutic agents by enhancing their antineoplastic activity and/or by reducing their side effects. An example of such a modulator is UFT ®, a new compound that combines Tegafur and Uracil. The articles included in this special issue explore the pharmacology, clinical efficacy and tolerability of UFT ® as a combined cytotoxic and metabolic modulator. It is shown in several studies that the development of UFT ® represents an important advance in the treatment of patients with metastatic cancer, whose prognoses and quality of life may be considerably improved by this modulator.
Publisher: S Karger AG
Number of pages: 40
Weight: 160 g
You may also be interested in...
Simply reserve online and pay at the counter when you collect. Available in shop from just two hours, subject to availability.
Thank you for your reservation
Your order is now being processed and we have sent a confirmation email to you at
When will my order be ready to collect?
Following the initial email, you will be contacted by the shop to confirm that your item is available for collection.
Call us on or send us an email at
Unfortunately there has been a problem with your order
Please try again or alternatively you can contact your chosen shop on or send us an email at